PMDA drug package insert
ドパストン静注25mg
PMDA Prescription drug · 大原薬品工業株式会社 · package insert Apr 13, 2026
Key facts
| Brand names | ドパストン静注25mg, ドパストン静注50mg |
|---|---|
| Nonproprietary names | レボドパ |
| Companies | 製造販売元／大原薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソニズム治療剤 |
| Therapeutic category codes | 871164 |
| YJ codes | 1164400A1045, 1164400A2041 |
| Approval numbers | 22000AMX02328000, 22000AMX02327000 |
| Package insert edition | 第2版 |
| Package insert date | Apr 13, 2026 |
| PMDA document key | 180095_1164400A1045_1 |
| PMDA company code | 180095 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: